rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Ryan Fisk

CFO and CBO

Company insider

Files Form 4 as: CFO and CBO, Andrx Corp /de/.

In numbers

Trades disclosed
2
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
24 Sep 2026
Last trade
24 Sep 2026
Last filed
28 Sep 2026

Companies traded

Where they are an officer
Andrx Corp /de/Officer · last 24 Sep 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
24 Sep 2026filed 28 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code A—170,692 at $0.00filing
24 Sep 2026filed 28 Sep 2026ADRX ADARx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—170,692 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

ORBIMED ADVISORS LLCDirector and 10% owner · Director and 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
Carl L. GordonDirector and 10% owner · Director and 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
Erez ChimovitsDirector · Director at ADARx Pharmaceuticals, filing Form 4 there in the last year
SR ONE CAPITAL MANAGEMENT, LLC10% owner · 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
LAV Biosciences Fund V, L.P.10% owner · 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year